Cargando…
CHID1 Is a Novel Prognostic Marker of Non-Small Cell Lung Cancer
There is an urgent need for identification of new prognostic markers and therapeutic targets for non-small cell lung cancer (NSCLC). In this study, we evaluated immune cells markers in 100 NSCLC specimens. Immunohistochemical analysis revealed no prognostic value for the markers studied, except CD16...
Autores principales: | Kovaleva, Olga V., Rashidova, Madina A., Samoilova, Daria V., Podlesnaya, Polina A., Tabiev, Rasul M., Mochalnikova, Valeria V., Gratchev, Alexei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795388/ https://www.ncbi.nlm.nih.gov/pubmed/33466316 http://dx.doi.org/10.3390/ijms22010450 |
Ejemplares similares
-
Immunosuppressive Phenotype of Esophagus Tumors Stroma
por: Kovaleva, Olga V., et al.
Publicado: (2020) -
Prognostic Significance of the Microbiome and Stromal Cells Phenotype in Esophagus Squamous Cell Carcinoma
por: Kovaleva, Olga, et al.
Publicado: (2021) -
Lung Microbiome Differentially Impacts Survival of Patients with Non-Small Cell Lung Cancer Depending on Tumor Stroma Phenotype
por: Kovaleva, Olga, et al.
Publicado: (2020) -
Macrophage Phenotype in Combination with Tumor Microbiome Composition Predicts RCC Patients’ Survival: A Pilot Study
por: Kovaleva, Olga V., et al.
Publicado: (2022) -
Tumor Associated Macrophages in Kidney Cancer
por: Kovaleva, Olga V., et al.
Publicado: (2016)